Legend Biotech Corp Other Gains Losses
Legend Biotech Corp (LEGN) reported Other Gains Losses of -$164.80 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Other Income
ifrs-full:OtherGainsLosses · last filed 2026-03-10
- Legend Biotech Corp other gains losses for the quarter ending 2025-12-31 was -$2.44M, a 102.19% decline year-over-year.
- Legend Biotech Corp other gains losses for the quarter ending 2025-09-30 was $354.00K.
- Legend Biotech Corp other gains losses for the quarter ending 2025-06-30 was -$108.13M, a 969.55% decline year-over-year.
- Legend Biotech Corp other gains losses for the quarter ending 2025-03-31 was -$54.51M, a 209.72% decline year-over-year.
| Period end | Other Gains Losses 3 month | Other Gains Losses 3 month as first filed | Other Gains Losses 6 month | Other Gains Losses 6 month as first filed | Other Gains Losses 9 month | Other Gains Losses 9 month as first filed | Other Gains Losses 12 month | Other Gains Losses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$2.44M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$2.08M derived: sum of 2 quarters · filed 2026-03-10 | -$110.21M derived: sum of 3 quarters · filed 2026-03-10 | -$164.80M 20-F · filed 2026-03-10 | ||||
| 2025-09-30 | $354.00K 6-K · filed 2025-11-12 | -$107.77M derived: sum of 2 quarters · filed 2025-11-12 | -$162.36M 6-K · filed 2025-11-12 | -$50.94M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2025-06-30 | -$108.13M 6-K · filed 2025-08-11 | -$162.64M 6-K · filed 2025-08-11 | -$51.30M derived: sum of 3 quarters · filed 2026-03-10 | -$112.95M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2025-03-31 | -$54.51M 6-K · filed 2025-05-13 | $56.83M derived: sum of 2 quarters · filed 2026-03-10 | -$4.82M derived: sum of 3 quarters · filed 2026-03-10 | $7.61M derived: sum of 4 quarters · filed 2026-03-10 | ||||
| 2024-12-31 | $111.34M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | $49.69M derived: sum of 2 quarters · filed 2026-03-10 | $62.12M derived: sum of 3 quarters · filed 2026-03-10 | $111.80M 20-F · filed 2026-03-10 | $109.38M 20-F · filed 2025-03-11 | |||
| 2024-09-30 | -$61.66M 6-K · filed 2025-11-12 | -$49.22M derived: sum of 2 quarters · filed 2025-11-12 | $459.00K 6-K · filed 2025-11-12 | $21.00K 6-K · filed 2024-11-12 | -$35.43M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2024-06-30 | $12.44M 6-K · filed 2025-08-11 | $62.12M 6-K · filed 2025-08-11 | $60.93M 6-K · filed 2024-08-09 | $26.22M derived: sum of 3 quarters · filed 2026-03-10 | $36.44M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2024-03-31 | $49.68M 6-K · filed 2025-05-13 | $49.51M 6-K · filed 2024-05-13 | $13.79M derived: sum of 2 quarters · filed 2026-03-10 | $24.01M derived: sum of 3 quarters · filed 2026-03-10 | $24.18M derived: sum of 4 quarters · filed 2026-03-10 | |||
| 2023-12-31 | -$35.89M derived: 20-F 12 month − 6-K 9 month · filed 2026-03-10 | -$25.67M derived: sum of 2 quarters · filed 2026-03-10 | -$25.50M derived: sum of 3 quarters · filed 2026-03-10 | -$24.80M 20-F · filed 2026-03-10 | $663.00K 20-F · filed 2024-03-19 | |||
| 2023-09-30 | $10.22M derived: 6-K 9 month − 6-K 6 month · filed 2024-11-12 | $10.39M derived: sum of 2 quarters · filed 2024-11-12 | $11.09M 6-K · filed 2024-11-12 | $12.20M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-06-30 | $168.00K derived: 6-K 6 month − 6-K 3 month · filed 2024-08-09 | $873.00K 6-K · filed 2024-08-09 | $1.98M derived: sum of 3 quarters · filed 2025-03-11 | $2.07M derived: sum of 4 quarters · filed 2025-03-11 | ||||
| 2023-03-31 | $705.00K 6-K · filed 2024-05-13 | $1.81M derived: sum of 2 quarters · filed 2025-03-11 | $1.90M derived: sum of 3 quarters · filed 2025-03-11 | |||||
| 2022-12-31 | $1.10M derived: 20-F 12 month − 6-K 9 month · filed 2025-03-11 | $1.20M derived: sum of 2 quarters · filed 2025-03-11 | $1.34M 20-F · filed 2025-03-11 | |||||
| 2022-09-30 | $94.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-20 | $243.00K 6-K · filed 2023-11-20 | ||||||
| 2022-06-30 | $149.00K 6-K · filed 2023-08-15 | |||||||
| 2021-12-31 | $317.00K 20-F · filed 2024-03-19 | |||||||
| 2020-12-31 | $113.00K 20-F · filed 2023-03-30 | |||||||
| 2019-12-31 | $1.06M 20-F/A · filed 2023-02-17 | $724.00K 20-F · filed 2022-03-31 |